Synonyms: ABBV-974 | ABBV974 | GLPG-1837
Compound class:
Synthetic organic
Comment: GLPG1837 is a CFTR potentiator class agent for cystic fibrosis patients with the CFTRG551D variant [1].
|
|
No information available. |
Summary of Clinical Use ![]() |
GLPG1837 was advanced to clinical evaluation. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT02707562 | Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation) | Phase 2 Interventional | Galapagos NV | GLPG1837 increases CFTR activity in G551D-cystic fibrosis patients. | 1 |